Skip to main content

Table 1 Anthropometric characteristics, fasting values of all subjects (n = 34) at the end of each intervention period.

From: Isomer-specific effects of CLA on gene expression in human adipose tissue depending on PPARγ2 P12A polymorphism: a double blind, randomized, controlled cross-over study

Preparation

linoleic acid

CLA MIX

cis-9,trans-11 CLA

trans-10,cis-12 CLA

P

Weight (kg)

84.2 (± 2.0)

84.2 (± 2.0)

84.1 (± 2.0)

84.0 (± 2.0)

0.851

BMI (kg/m2)

26.1 (± 0.5)

26.1 (± 0.4)

26.0 (± 0.4)

26.0 (± 0.5)

0.900

Waist (cm)

102.1 (± 1.5)a

102.1 (± 1.6)a

102.3 (± 1.5) a

101.2 (± 1.5) b

0.072

Hip (cm)

104.8 (± 1.0)

104.8 (± 1.0)

104.8 (± 1.0)

104.0 (± 1.0)

0.824

Waist/hip ratio

0.97 (± 0.01)

0.97 (± 0.01)

0.98 (± 0.01)

0.97 (± 0.01)

0.645

Plasma glucose (mg/dl)

96.5 (± 1.4)

98.2 (± 1.5)

97.5 (± 1.5)

96.5 (± 1.4)

0.487

HOMA-IR

3.0(± 0.3)

3.2(± 0.2)

3.1(± 0.3)

2.9(± 0.2)

0.693

Triacylglycerols (mg/dl)

127.0 (± 10.1)

119.1 (± 8.9)

124.4 (± 10.8)

124.7 (± 10.6)

0.787

Total cholesterol (mg/dl)

223.9(± 7.3)

225.3(± 6.8)

223.6(± 7.2)

226.5(± 6.8)

0.783

LDL cholesterol (mg/dl)

56.3(± 2.6)

56.5(± 2.3)

56.7(± 2.5)

54.6(± 2.8)

0.268

HDL cholesterol (mg/dl)

145.4(± 6.0)

143.1(± 5.8)

145.7(± 6.3)

146.4(± 5.7)

0.772

SBP (mmHg)

127 (± 3)

127 (± 3)

128 (± 3)

126 (± 2)

0.901

DBP (mmHg)

80(± 2)

79 (± 2)

80 (± 2)

80 (± 2)

0.871

  1. Values are expressed as mean ± SEM. CLA, conjugated linoleic acid; BMI, body mass index, DBP diastolic Blood pressure, SBP systolic blood pressure LDL low-density lipoprotein cholesterol, HDL high-density lipoprotein cholesterol, HOMA-IR; homeostasis model assessment-insulin resistance, intervention-dependent changes were compared using multiple ANOVA.